« Too Many Stents Being Used in Heart Surgery | Main

Boston Scientific’s Stent Sales Fall

Boston Scientific Corp. said fourth-quarter sales of its Taxus drug-coated stent fell nearly 12 percent from the previous quarter, but the medical device maker expects the slumping stent market to rebound from recent safety worries.

Posted by Michael Monheit on January 16, 2007 08:22 AM |

TrackBack

TrackBack URL for this entry:
http://blogs.legalview.com/mt-admin/mt-tb.cgi/914

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)